Filters

IFN-beta Antibody, Cy7 Conjugated

IFN-beta Antibody, Cy7 Conjugated size: 0.1ml 350

Price 350
Size 0.1ml
Long name Cy7 Conjugated, IFN-beta Polyclonal Antibody
CategoryConjugated Primary Antibodies
ConjugationCy7
Host OrganismRabbit (Oryctolagus cuniculus)
Target AntigenIFN-beta
SpecificityThis is a highly specific antibody against IFN-beta
ModificationUnmodified
Modification siteNone
ClonalityPolyclonal
ClonePolyclonal antibody
Concentration1ug per 1ul
Immunogen_range130-180/187
SourceKLH conjugated synthetic peptide derived from human IFN-beta
Gene ID number3456
Swiss ProtP01574
Tested applicationsIF(IHC-P)
Recommended dilutionsIF(IHC-P)(1:50-200)
CrossreactivityHuman
Crossreactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Antigen background antibacterial and anticancer activities, Has antiviral
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA
Excitation Emission743nm/767nm
Synonyms IFNA@ IFL IFN IFN-ALPHA IFNA13 IFN-alphaD
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24°
ConjugatedThese antibodies are excite for emission at 650 nm and detected at a 676 nm wavelengths
Gene targetIFN-beta Conjugated
Short name Conjugated, IFN-beta Antibody
Technique antibodies against human proteins, antibodies for, antibody Conjugates, Antibody
LabelCy7
Alternative name cyanine 7 coupled, Interferon-b (Antibody to)
Alternative techniqueantibodies
Identity 5417
Gene IFNA1
Long gene name interferon alpha 1
Synonyms name IFN-alpha 1b interferon alpha 1b
Locus 9p21, 3
Discovery year 1993-01-14
Entrez gene record 3439
Pubmed identfication 1385305
RefSeq identity NM_024013
Classification Interferons
Havana BLAST/BLAT OTTHUMG00000019673

Subscribe to our Newsletter